Browse > Article

Cigarette Smoking and Polymorphism of the Paraoxonase 1 Gene as Risk factors for Lung Cancer  

Lee, Chul-Ho (Department of Preventive Medicine, College of Medicine, Chungbuk National University)
Lee, Kye Young (Department of Internal Medicine, Dankook University College of Medicine)
Hong, Yun-Chul (Department of Preventive Medicine, Seoul National University College of Medicine)
Choe, Kang-Hyeon (Department of Internal Medicine, Chungbuk National University Hospital)
Kim, Yong-Dae (Department of Preventive Medicine, College of Medicine, Chungbuk National University)
Kang, Jong-Won (Department of Preventive Medicine, College of Medicine, Chungbuk National University)
Kim, Heon (Department of Preventive Medicine, College of Medicine, Chungbuk National University)
Hong, Jang Soo (Department of Internal Medicine, Chungbuk National University Hospital)
Publication Information
Tuberculosis and Respiratory Diseases / v.58, no.5, 2005 , pp. 490-497 More about this Journal
Abstract
Background : The paraoxonase enzyme plays a significant role in the detoxification of various organophosphorous compounds in mammals, and paraoxonase (PON) 1 is one of the endogenous free-radical scavenging systems in the human body. In this study, we investigated the interaction between cigarette smoking and the genetic polymorphism of PON1 with lung cancer in Korean males. Methods : Three hundred thirty five patients with lung cancer and an equal number of age-matched controls were enrolled in this study. Every subject was asked to complete a questionnaire concerning their smoking habits and alcohol drinking habits. A 5' exonuclease assay (TaqMan) was used to genotype the PON1 Q192R polymorphism. The effects of smoking habits and drinking habits, the PON1 Q192R polymorphism and their interactions were statistically analyzed. Results : Cigarette smoking and the Q/Q genotype of PON1 were significant risk factors for lung cancer. Individuals carrying the Q/Q genotype of PON1 were at a higher risk for lung cancer as compared with those individuals carrying the Q/R or R/R genotype (odds ratio, 2.84; 95% confidence interval, 1.69 - 4.79). When the groups were further stratified by the smoking status, the Q/Q PON1 was associated with lung cancer among the current or ex-smokers (odds ratio, 2.56; 95% confidence interval, 1.52 - 4.31). Current smokers or ex-smokers who had the Q/Q genotype showed an elevated risk for lung cancer (odds ratio: 15.50, 95% confidence interval: 6.76 - 35.54) as compared with the group of subjects who never smoked, and had the Q/R or R/R genotype. The odds ratios (95% confidence interval) of smokers with the PON1 Q/Q type compared to the nonsmokers with the PON1 Q/R or R/R type were 53.77 (6.55 - 441.14) for squamous cell carcinoma, 6.25 (1.38 - 28.32) for adenocarcinoma, and 59.94 (4.66 - 770.39) for small cell carcinoma, and these results were statistically significant. Conclusion : These results suggest that cigarette smoking and the PON1 Q/Q genotype are risk factors for lung cancer. The combination of cigarette smoking and the PON1 Q/Q genotype significantly increased the lung cancer risk irrespective of the histologic type of cancer.
Keywords
Lung cancer; Paraoxonase 1; Cigarette smoking; TaqMan real-time PCR;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Cohen AJ. Outdoor air pollution and lung cancer. Environ Health Perspect 2000;108:743-50   DOI
2 Caporaso N. Selection of candidate genes for population studies. IARC Sci Publ 1999;148:23-36
3 Pond AL, Chambers HW, Chambers JE. Organopho-sphate detoxication potential of various rat tissues via A-esterase and aliesterase activities. Toxicol Lett 1995;78:245-52   DOI   ScienceOn
4 Hong SH, Song J, Min WK, Kim JQ. Genetic variations of the paraoxonase gene in patients with coronary artery disease. Clin Biochem 2001;34:475-81   DOI   ScienceOn
5 Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334-6   DOI   ScienceOn
6 Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Nacak M, Tapanyigit EE, Roots I. Paraoxonase 1 mutations in a Turkish population. Toxicol Appl Pharmacol 1999;157:174-7   DOI   ScienceOn
7 Potter JD, McMichael AJ. Alcohol, beer and lung cancer: a meaningful relationship? Int J Epidemiol 1984;13:240-2   DOI   PUBMED
8 Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498-507   DOI   ScienceOn
9 Senti M, Tomas M, Anglada R, Elosua R, Marrugat J, Covas MI, et al. Interrelationship of smoking, paraoxonase activity, and leisure time physical activity:a population-based study. Eur J Intern Med 2003;14:178-84   DOI   ScienceOn
10 Kondo I, Yamamoto M. Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease. Brain Res 1998;806:271-3   DOI   ScienceOn
11 Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993;3:73-6   DOI   ScienceOn
12 Wild CP, Law GR, Roman E. Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutat Res 2002;499:3-12   DOI
13 American Cancer Society. Tobacco use. In: American Cancer Society, editors. Cancer facts & figures 2001. Atlanta, GA: American Cancer Society; 2001. p. 29-32
14 Mango GW, Johnston CJ, Reynolds SD, Finkelstein JN, Plopper CG, Stripp BR. Clara cell secretory protein deficiency increases oxidant stress response in conducting airways. Am J Physiol 1998;275:L348-56
15 Romanova LK, Goriachkina VL. Cytophysiology of lung bronchiolar secretory cells: source of inflammation 'antimediators'. Arkh Patol 1999;61:20-7
16 La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, et al. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999;119-120:379-88   DOI   ScienceOn
17 Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, et al. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. J Natl Cancer Inst 2003;95:812-8   DOI   ScienceOn
18 Bartsch H, Rojas M, Alexandrov K, Camus AM, Castegnaro M, Malaveille C, et al. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans. Pharmacogenetics 1995;5:S84-90   DOI
19 Li WF, Furlong CE, Costa LG. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett 1995;76:219-26   DOI   ScienceOn
20 Central Cancer Registry Center in Korea. Annual report of the central cancer registry in Korea. Seoul: Ministry of Health and Welfare; 2003
21 World Health Organization. Tobacco or health: a global status report. Geneva: World Health Organization; 1997. p. 10-48
22 Rodrigo L, Hernandez AF, Lopez-Caballero JJ, Gil F, Pla A. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Interact 2001;137:123-37   DOI   ScienceOn
23 Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, et al. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 2002;106:484-90   DOI   ScienceOn
24 Kim YD, Lee CH, Nan HM, Kang JW, Kim H. Effects of genetic polymorphisms in metabolic enzymes on the relationships between 8-hydroxydeoxyguanosine levels in human leukocytes and urinary 1-hydroxy-pyrene and 2-naphthol concentrations. J Occup Health 2003;45:160-7   DOI   ScienceOn
25 Furlong CE, Li WF, Richter RJ, Shih DM, Lusis AJ, Alleva E, et al. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicol 2000;21:91-100